Ethicon, a part of J&J, received expanded FDA indication for its EVARREST Fibrin Sealant Patch to be used to help control bleeding during adult liver surgeries. The device is bioabsorbable and contains human thrombin and fibinogen proteins that participate in clot formation.
It retains its strength and stickiness while it’s still around, helping to stop difficult to control bleeding regions that are common when working on the liver. According to the company, the EVARREST patch had a nearly double improvement in ability to stop challenging bleeding when compared to current standard of care.
Here’s an animation showing off the EVARREST mode of action: